ID   sfP3HR-1
AC   CVCL_C5DN
SY   serum free P3HR-1
DR   Wikidata; Q116050493
RX   CelloPub=CLPUB00725;
CC   Group: Serum/protein free medium cell line.
CC   Population: African; Nigerian.
CC   Sequence variation: Mutation; HGNC; 7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Tyr163His (c.487T>C); ClinVar=VCV000376680; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Glu287Ter (c.859G>T); Zygosity=Unspecified (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2676 ! P3HR-1
SX   Male
AG   7Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 02-05-24; Version: 4
//
RX   CelloPub=CLPUB00725;
RA   Baglia L.A.;
RT   "Survey of the secretion of immunoreactive pituitary proteins by
RT   transformed serum-free B lymphoblastoid cell lines.";
RL   Thesis PhD (1993), Ohio State University, United States.
//